Daclatasvir - PDFSEARCH.IO - Document Search Engine

Daclatasvir
Results: 9

#	Item
1	State of Illinois Illinois Department of Public Health Ryan White Part B ADAP Medication Assistance Program (MAP) Application for Pre Approval of Hepatitis C Medication Assistance The following medications are n o w avai Add to Reading List Source URL: hivcareconnect.com Language: English - Date: 2016-05-03 16:46:58 Breakthrough therapy Gilead Sciences Healthcare-associated infections Carbamates Cyclopropanes Ledipasvir/sofosbuvir Sofosbuvir Ombitasvir/paritaprevir/ritonavir Hepatitis C Daclatasvir Ribavirin Hepatitis
2	NLT-gruppens yttrande till landstingen gällande nya läkemedel vid kronisk hepatit C: simeprevir (Olysio) sofosbuvir (Sovaldi) och daclatasvir (Daklinza) samt kommentar kring ledipasvir/sofosbuvir (Harvoni) Add to Reading List Source URL: www.janusinfo.se Language: Swedish - Date: 2014-12-22 02:37:28
3	ANRS HC 32 QUATTRO Etude pilote évaluant l’efficacité et la tolérance d’une QUADRITHERAPIE associant Asunaprevir, Daclatasvir, Ribavirine et Peginterféron alpha-2a chez les patients infectés par le VHC de génot Add to Reading List Source URL: www.anrs.fr Language: French - Date: 2014-12-15 08:45:11
4	New drug could eliminate hepatitis C in 15 years The Pharmaceutical Journal, 10 SEP 2014, By Janna Lawrence Daclatasvir is estimated to cure chronic hepatitis C infection in up to 99% of cases when used in combination wi Add to Reading List Source URL: www.hepcassoc.org Language: English - Date: 2014-09-15 11:42:23 Health Hepatitis Hepatitis C Protease inhibitors Interferon Ribavirin Hepatitis C and HIV co-infection Hepatocellular carcinoma Viral hepatitis Medicine Biology Antivirals
5	ALLY Trial Demonstrates High Cure Rates for Investigational Daclatasvir and Sofosbuvir Combination among Genotype 3 Hepatitis C Patients Daclatasvir+sofosbuvir regimen achieves SVR12 in 90% of treatment-naïve and 86% of Add to Reading List Source URL: www.hepcassoc.org Language: English - Date: 2014-11-10 11:48:39 Hepatitis C and HIV co-infection Ribavirin Biology Genetics Medicine MiR-122 Hepatitis Protease inhibitors Hepatitis C
6	Phase 3 UNITY Trials Demonstrate High Cure Rates for Investigational, All-Oral Daclatasvir TRIO Fixed-Dose Combination in Genotype 1 Hepatitis C Patients, Including Those with Cirrhosis Daclatasvir TRIO achieves 98% cure Add to Reading List Source URL: www.hepcassoc.org Language: English - Date: 2014-11-10 11:48:36 Health Hepatitis C Protease inhibitors Hepatitis Cirrhosis Ribavirin Hepatitis C and HIV co-infection Telaprevir Medicine Antivirals Hepatology
7	Drugs in Development: Phase 3, Genotype 1b: BMS’s Daclatasvir Plus Asunaprevir Combination Add to Reading List Source URL: www.hcvadvocate.org Language: English - Date: 2014-09-18 02:13:21 Antivirals Hepatitis Viral hepatitis Hepatology Hepatitis C Interferon Cirrhosis Hepatitis C and HIV co-infection Hepacivac Medicine Health Biology
8	Drugs in Development: Phase 3, Genotype 1: BMS’s Daclatasvir Plus Sofosbuvir Combination Add to Reading List Source URL: www.hcvadvocate.org Language: English - Date: 2014-09-18 02:13:23 Hepatitis C Viral hepatitis Hepatitis Ribavirin Biology Protease inhibitors Hepatitis C and HIV co-infection Hepacivac Antivirals Medicine Health
9	Drugs in Development: Phase 3, Genotype 2 & 3: BMS’s Daclatasvir Plus Sofosbuvir Combination Add to Reading List Source URL: www.hcvadvocate.org Language: English - Date: 2014-09-18 02:13:25 Hepatitis Medicine Genetics Protease inhibitors Hepatitis C and HIV co-infection Hepatitis C virus Health Hepatitis C Viral hepatitis

UPDATE